Mgr. Jan Kučera, Ph.D.
Researcher II, Department of Physical Activities and Health Sciences
Total number of publications: 35
2024
-
Correlating plasma protein profiles with symptomatology and treatment response in acute phase and early remission of major depressive disorder
Frontiers in Psychiatry, year: 2024, volume: 15, edition: September 2024, DOI
-
Endocrine disruption of adipose physiology: Screening in SGBS cells
Journal of Applied Toxicology, year: 2024, volume: 44, edition: 11, DOI
-
Epigenetic and transcriptional control of adipocyte function by centenarian-associated SIRT6 N308K/A313S mutant
CLINICAL EPIGENETICS, year: 2024, volume: 16, edition: 1, DOI
-
Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model
CNS NEUROSCIENCE & THERAPEUTICS, year: 2024, volume: 30, edition: 2, DOI
-
Potenciál GLP-1 receptorového agonisty v normalizaci dysmetabolického fenotypu indukovaného olanzapinem o potkana
Year: 2024, type: Appeared in Conference without Proceedings
-
Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model
Biomedicine and Pharmacotherapy, year: 2024, volume: 176, edition: July 2024, DOI
-
Potential of a GLP-1 receptor agonist in normalizing the olanzapine-induced dysmetabolic phenotype in the rat
Year: 2024, type: Appeared in Conference without Proceedings
-
Synergické účinky dulaglutidu a omezení příjmu potravy v prevenci metabolických nežádoucích účinků vyvolaných olanzapinem u potkanů
Year: 2024, type: Conference abstract
2023
-
Biological factors and self-perception of stress in relation to freeze-like response in humans
Psychoneuroendocrinology, year: 2023, volume: 158, edition: December 2023, DOI
-
Plazmatické hladiny FSTL1 a FSLT5 predikují obnovu funkce levé komory u pacientů s nově zjištěnou dilatační kardiomyopatií
Year: 2023, type: Conference abstract